PT1133238E - Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem - Google Patents

Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem

Info

Publication number
PT1133238E
PT1133238E PT99958115T PT99958115T PT1133238E PT 1133238 E PT1133238 E PT 1133238E PT 99958115 T PT99958115 T PT 99958115T PT 99958115 T PT99958115 T PT 99958115T PT 1133238 E PT1133238 E PT 1133238E
Authority
PT
Portugal
Prior art keywords
protein composition
preapping
formula containing
child formula
composition
Prior art date
Application number
PT99958115T
Other languages
English (en)
Inventor
Rafael Berrocal
Rolf Jost
Zdenek Kratky
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8234377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1133238(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PT1133238E publication Critical patent/PT1133238E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2210/00Physical treatment of dairy products
    • A23C2210/20Treatment using membranes, including sterile filtration
    • A23C2210/206Membrane filtration of a permeate obtained by ultrafiltration, nanofiltration or microfiltration

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Water Supply & Treatment (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99958115T 1998-11-24 1999-11-17 Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem PT1133238E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203960 1998-11-24

Publications (1)

Publication Number Publication Date
PT1133238E true PT1133238E (pt) 2004-09-30

Family

ID=8234377

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99958115T PT1133238E (pt) 1998-11-24 1999-11-17 Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem

Country Status (10)

Country Link
EP (1) EP1133238B1 (pt)
AT (1) ATE271783T1 (pt)
AU (1) AU771034B2 (pt)
BR (1) BR9915573B1 (pt)
DE (1) DE69919019T2 (pt)
DK (1) DK1133238T3 (pt)
ES (1) ES2226466T3 (pt)
NZ (1) NZ511562A (pt)
PT (1) PT1133238E (pt)
WO (1) WO2000030461A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4250254B2 (ja) * 1999-04-22 2009-04-08 雪印乳業株式会社 ホエータンパク質濃縮物及びその製造法
FR2809595B1 (fr) * 2000-06-05 2003-10-03 B S A Derive laitier presentant une composition minerale et en acides amines selectivement modifiee, procedes pour sa fabrication, et utilisation.
US20050089612A1 (en) * 2001-12-21 2005-04-28 Pokka Corporation Powdery drinks and process for producing the same
US20050181093A1 (en) * 2004-02-18 2005-08-18 Achs Ronald A. Concentrated-protein food product and process
WO2006039759A1 (en) * 2004-10-15 2006-04-20 Murray Goulburn Co-Operative Co Limited Improved milk powder and method of manufacture
EP1680967A1 (fr) * 2005-01-14 2006-07-19 Forum Media Productions SPRL Compositions diététiques à base d'isolat de protéines solubles de lait
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
NL1033698C2 (nl) * 2007-04-16 2008-10-20 Friesland Brands Bv Functioneel serumeiwitproduct voor toepassing in kindervoeding en therapeutische samenstellingen, en werkwijzen ter bereiding daarvan.
AU2008297417A1 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of somatostatin-14 as a therapeutic agent
WO2009039993A2 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
JP2010539064A (ja) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療への適用のための甲状腺刺激ホルモン放出ホルモン
WO2009033719A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a deslorelin and mastoparan as a therapeutic agent
EP2187911A1 (en) 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine
JP2010539024A (ja) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト ガストリン−1およびG−Pen−GRGDSPCAの治療学的な使用
WO2009033767A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009033681A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Cyclo-argd as a therapeutic agent
RU2010114022A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Сочетание спленопентина и тимопентина и их применение в лекарственном средстве
WO2009033804A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of gamma- endorphin as a therapeutic agent
US20100184708A1 (en) 2007-09-11 2010-07-22 Dorian Bevec Use of gly-pro-glu-oh (gpe) as a therapeutic agent
EP2187929A2 (en) 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent
WO2009040083A2 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
US20100197604A1 (en) 2007-09-11 2010-08-05 Dorian Bevec Use of peptide as a therapeutic agent
KR20100059867A (ko) 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 밴드 3 단백질 및 pacap-27의 용도
WO2009033785A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009039970A1 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of bpp-b as a therapeutic agent
WO2009039986A2 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent
CA2699084A1 (en) 2007-09-11 2009-04-16 Dorian Bevec Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
EP2207560A2 (en) 2007-09-11 2010-07-21 Mondobiotech Laboratories AG Use of fibronectin fragment (196-203) as a therapeutic agent
WO2009046847A2 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of peptide ll-37 as a therapeutic agent
KR20110056452A (ko) 2008-09-09 2011-05-30 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드의 용도
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
DK2493325T3 (da) 2009-10-28 2021-02-15 Valio Ltd Valleproteinprodukt og en fremgangsmåde til dets fremstilling
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин
FI124323B (fi) 2011-02-18 2014-06-30 Valio Oy Maitopohjainen tuote ja menetelmä sen valmistamiseksi
NL2006662C2 (en) * 2011-04-26 2012-10-29 Friesland Brands Bv Method of making a milk protein composition.
FI124711B (fi) * 2011-07-06 2014-12-15 Valio Oy Maitopohjainen formulaatio
CN103781368A (zh) 2011-07-13 2014-05-07 弗里斯兰品牌有限公司 具有低lps的乳品类组合物
WO2013009185A1 (en) 2011-07-13 2013-01-17 Friesland Brands B.V. Composition with improved digestibility of proteins
FI125332B (fi) 2011-11-11 2015-08-31 Valio Oy Menetelmä maitotuotteen valmistamiseksi
AU2012373361B2 (en) * 2012-03-12 2016-10-27 N.V. Nutricia Process for the humanization of animal skim milk and products obtained thereby
EP2730170B1 (de) 2012-11-13 2016-02-10 DMK Deutsches Milchkontor GmbH Allergenfreie Nahrungsmittelzusammensetzungen
WO2014163485A1 (en) 2013-04-03 2014-10-09 N.V. Nutricia Process and system for preparing dry milk formulae
WO2014163486A1 (en) 2013-04-03 2014-10-09 N.V. Nutricia Process and system for preparing dry milk formulae
WO2015041515A1 (en) 2013-09-19 2015-03-26 N.V. Nutricia Improved process for the humanization of animal skim milk
WO2015178761A1 (en) 2014-05-19 2015-11-26 N.V. Nutricia Formulas comprising optimised amino acid profiles
CN107809909B (zh) 2015-06-25 2021-05-11 诺帝柏欧 特别适用于有机食品业的去矿物质化乳蛋白质组合物的生产方法以及去矿物质化乳蛋白质组合物
LT3471561T (lt) * 2016-06-21 2020-08-10 Arla Foods Amba Pagerintų mitybos produktų, turinčių pieno baltymus ir pieno sacharidus, gamybos būdas
WO2018028765A1 (en) 2016-08-08 2018-02-15 Compagnie Gervais Danone Process for producing infant formula products and dairy products
WO2018028764A1 (en) 2016-08-08 2018-02-15 Compagnie Gervais Danone Process for producing infant formula products and acidic dairy products
EP3542634B1 (de) * 2018-03-21 2021-06-30 DMK Deutsches Milchkontor GmbH Milchproteinkonzentrate mit vermindertem aschegehalt
DK3893654T3 (da) 2019-09-12 2023-10-16 Hipp & Co Fremgangsmåder til fremstilling af perchloratdepleteret mælk
EP4307909A1 (en) 2021-03-17 2024-01-24 Hipp & Co Processes for the manufacture of perchlorate depleted milk products
WO2023094398A1 (en) 2021-11-23 2023-06-01 Frieslandcampina Nederland B.V. Infant formula containing serum protein concentrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497836A (en) * 1982-08-06 1985-02-05 Dairy Technology Ltd. Modified whey product and process including ultrafiltration and demineralization
WO1994013148A1 (en) * 1992-12-11 1994-06-23 Immunotec Research Corporation Ltd. Process for producing an undernatured whey protein concentrate
CO4560537A1 (es) * 1992-12-28 1998-02-10 Nestle Sa Composicion lactea y procedimiento de preparacion
DE4344342C2 (de) * 1993-12-23 1996-08-08 Milupa Ag Molkenprotein-dominante Säuglingsnahrung
AU700748B2 (en) * 1994-09-16 1999-01-14 New Zealand Dairy Board Physical separation of casein and whey proteins
SE506854C2 (sv) * 1996-06-27 1998-02-16 Tetra Laval Holdings & Finance Sätt att framställa aseptisk konsumtionsmjölk

Also Published As

Publication number Publication date
BR9915573A (pt) 2001-08-14
AU771034B2 (en) 2004-03-11
DE69919019T2 (de) 2004-11-25
EP1133238A1 (fr) 2001-09-19
ATE271783T1 (de) 2004-08-15
WO2000030461A1 (fr) 2000-06-02
EP1133238B1 (fr) 2004-07-28
AU1556600A (en) 2000-06-13
BR9915573B1 (pt) 2010-11-30
NZ511562A (en) 2003-10-31
DE69919019D1 (de) 2004-09-02
DK1133238T3 (da) 2004-10-25
ES2226466T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
PT1133238E (pt) Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem
DE69931275D1 (de) Verfahren zur herstellung von kaese sowie kaeseprodukte
ATE243747T1 (de) Herstellung von antikörpern
CA2259761A1 (en) A continuous process of dynamic high-pressure homogenization for the denaturation of proteins
DE69308529T3 (de) Verfahren zur Herstellung von einer Milchzusammensetzung
ATE236532T1 (de) Saures getränk
BR9107206A (pt) Processo para produzir uma variante de proteina que evoca uma resposta imunogenica diminuida em animais,produtos obtidos,composicao e uso
DE59309513D1 (de) Verfahren zur Herstellung von Polysuccinimid, Polyasparaginsäure und ihrer Salze
PE102698A1 (es) Sustituto de leche y proceso para su fabricacion
DK317988A (da) Fremgangsmaade og praeparat til oegning af proteinindholdet i maelk i maelkeproducerende dyr
DE69329923T2 (de) Molkenprotein und molkenproteinhydrolysate, und verfahren zur herstellung
ATE95032T1 (de) Magermilchbehandlungsverfahren.
ATE92720T1 (de) Verfahren zur modifizierung von molke.
DE69201677D1 (de) Milde mundhygienische Zusammensetzung zum Konservieren von Geschmack.
DE3877338T2 (de) Isolierung einer immunoglobulinreichen molke-fraktion.
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
ATE399466T1 (de) Flüssig-kolostrum für milchprodukte
ATE103779T1 (de) Brausekomponente und verfahren zu ihrer herstellung.
ATE118982T1 (de) Verfahren zur herstellung von transparenten milchmolkeproteinen und milchmolkeproteinprodukte.
ATE119353T1 (de) Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen.
DE69814204T2 (de) Verfahren zur Herstellung von 2,2'-bis(Hydroxymethyl)alkanal und 2,2'-bis(Hydroxymethyl)alkansäure
DE60023122D1 (de) Verfahren zur verhinderung von hypocalcämie in gebärenden tieren und dazu geeignete zusammensetzungen
FR2552631B1 (fr) Lait et produits laitiers appauvris ou non en calcium et enrichis en magnesium
BR9004693A (pt) Solucao aquosa,processo para aumentar a concentracao de proteina de uma proteina em uma solucao aquosa,e composicao farmaceutica
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.